UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

Insufficiency of PTH action on bone in uremia

Kidney international, 2006-07, Vol.70 (S102), p.S34-S36

2006

Volltextzugriff (PDF)

Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells

Kidney international, 2007-04, Vol.71 (8), p.738-743

2007

Volltextzugriff (PDF)

Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy

Nephrology, dialysis, transplantation, 2007-06, Vol.22 (6), p.1547-1557

2007

Volltextzugriff (PDF)

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients

Kidney international, 2005-03, Vol.67 (3), p.1171-1178

2005

Volltextzugriff (PDF)

No change in circulating osteoprotegerin levels by intravenous calcitriol therapy among dialysis patients with secondary hyperparathyroidism

Clinical nephrology, 2006-02, Vol.65 (2), p.149

2006

Volltextzugriff (PDF)

Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone

Nephrology, dialysis, transplantation, 2005-09, Vol.20 (9), p.1904-1911

2005

Volltextzugriff (PDF)

Sevelamer Hydrochloride and Calcium Bicarbonate Reduce Serum Fibroblast Growth Factor 23 Levels in Dialysis Patients

Therapeutic apheresis and dialysis, 2005-08, Vol.9 (4), p.336-339

2005

Volltextzugriff (PDF)

Intravenous Calcitriol Therapy Increases Serum Concentrations of Fibroblast Growth Factor-23 in Dialysis Patients with Secondary Hyperparathyroidism

Nephron. Clinical practice, 2005-01, Vol.101 (2), p.c94-c99

2005

Volltextzugriff (PDF)

Role of fibroblast growth factor 23 in health and in chronic kidney disease

Current opinion in nephrology and hypertension, 2005-07, Vol.14 (4), p.325-329

2005

Volltextzugriff (PDF)

Uremic toxin and bone metabolism

Journal of bone and mineral metabolism, 2006-03, Vol.24 (2), p.172-175

2006

Volltextzugriff (PDF)

Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats

Nephrology, dialysis, transplantation, 2006-10, Vol.21 (10), p.2768-2774

2006

Volltextzugriff (PDF)

Serum Pro-hepcidin as an Indicator of Iron Status in Dialysis Patients

Therapeutic apheresis and dialysis, 2008-06, Vol.12 (3), p.226-231

2008

Volltextzugriff (PDF)

Alteration of mRNA expression of molecules related to iron metabolism in adenine-induced renal failure rats: a possible mechanism of iron deficiency in chronic kidney disease patients on treatment

Nephrology, dialysis, transplantation, 2008-06, Vol.23 (6), p.1886-1891

2008

Volltextzugriff (PDF)

Direct Injection of Calcitriol or Its Analog Improves Abnormal Gene Expression in the Hyperplastic Parathyroid Gland in Uremia

American journal of nephrology, 2008-01, Vol.28 (1), p.59-66

2008

Volltextzugriff (PDF)

Intravenous Calcitriol Therapy Increases Serum Concentrations of Fibroblast Growth Factor-23 in Dialysis Patients with Secondary Hyperparathyroidism

Nephron, 2005-10, Vol.101 (2), p.c94

2005

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)
Japanisch
(7)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Insufficiency of PTH action on bone in uremia

Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells

Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients

No change in circulating osteoprotegerin levels by intravenous calcitriol therapy among dialysis patients with secondary hyperparathyroidism

Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone

Sevelamer Hydrochloride and Calcium Bicarbonate Reduce Serum Fibroblast Growth Factor 23 Levels in Dialysis Patients

Intravenous Calcitriol Therapy Increases Serum Concentrations of Fibroblast Growth Factor-23 in Dialysis Patients with Secondary Hyperparathyroidism

Role of fibroblast growth factor 23 in health and in chronic kidney disease

Uremic toxin and bone metabolism

Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats

Serum Pro-hepcidin as an Indicator of Iron Status in Dialysis Patients

Alteration of mRNA expression of molecules related to iron metabolism in adenine-induced renal failure rats: a possible mechanism of iron deficiency in chronic kidney disease patients on treatment

Direct Injection of Calcitriol or Its Analog Improves Abnormal Gene Expression in the Hyperplastic Parathyroid Gland in Uremia

Intravenous Calcitriol Therapy Increases Serum Concentrations of Fibroblast Growth Factor-23 in Dialysis Patients with Secondary Hyperparathyroidism

Suchergebnisse filtern